HRL Laboratories
We're Hiring!
HRL Laboratories Company Growth, Stability & Outlook
What People Are Saying About HRL Laboratories
-
Strategic Partnerships: An exclusive licensing and manufacturing agreement with MACOM for HRL’s 40nm GaN-on-SiC process moves core technology toward broader commercialization. Additional 2025 collaborations (including DARPA-funded programs and quantum work with Boeing) reinforce a partner-led scaling model.
-
Product Line Growth: Opening a 60,000-square-foot Camarillo facility expanded infrared hardware fabrication and testing, with large-format focal plane capacity rising from roughly 15 to over 75 per year. GaN-on-SiC reaching Manufacturing Readiness Level 6 and a planned transition to a volume manufacturer signal movement from R&D into productization.
-
Investor Backing & Capital Strength: Completion of IBM’s acquisition in August 2026 provides institutional resources to integrate HRL’s silicon-spin qubits, quantum sensing, and materials capabilities into a larger roadmap. Independent coverage characterized the deal as adding a second technological approach to IBM’s quantum strategy.
